Doç. Dr. Ant Uzay
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Multiple Myeloma 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lymphoma, Non-Hodgkin 2 publications
- Lymphoma, Large B-Cell, Diffuse 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Akut Lenfoblastik Lösemi (ALL)
- Akut Miyeloid Lösemi (AML)
- Anemi
- Demir Eksikliği Anemisi
- ITP Hastalığı
- KML (Kronik Miyeloid Lösemi)
- Multipl Miyelom
- Von Willebrand Hastalığı
- Kemik İliği Nakli
- Kemik İliği Hastalıkları
CV
Education and experience
Experience
- 2009 - 2010GATA Haydarpaşa Eğitim ve Araştırma Hastanesi / Hematoloji Uzmanı Tabip Asteğmenacibadem.com.tr
- 2005Acıbadem Sağlık Grubuacibadem.com.tr
Education
- 2009Marmara Üniversitesi Tıp Fakültesi, Hematoloji, Üst Uzmanlıkacibadem.com.tr
- 2005Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 2000Trakya Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologyacibadem.com.trFrom source
- Department name at the sourceKemik İliği Nakli Merkezi (Erişkin)acibadem.com.trFrom source
- InstitutionAcıbadem Atakent Hastanesiacibadem.com.trFrom source
- Area of workMultiple MyelomaExtracted from 3 publications · Model version —From source
- Publications34 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 20:46https://www.acibadem.com.tr/doktor/ant-uzay/acibadem.com.tr
Scientific work
Publications on Multiple Myeloma
-
Extreme Thrombocytosis in MECOM-Rearranged Acute Myeloid Leukemia: A Diagnostic and Therapeutic Challenge
Indian Journal of Hematology and Blood Transfusion, 2026
DOI 10.1007/s12288-026-02335-5 Source: OpenAlex
-
Post-Transplant Lymphoproliferative Disorder After Successful Treatment of Graft-Versus Host Disease Following Liver Transplantation
Transplantation Proceedings, 2026
DOI 10.1016/j.transproceed.2026.09.018 PMID 42881047 Source: OpenAlex
-
BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility
Medicina, 2026
DOI 10.3390/medicina62081502 PMID 42654399 Open-access full textSource: OpenAlex
-
Pulmonary outcomes after hematopoietic stem cell transplantation: A comparative study of autologous and allogeneic recipients
European Respiratory Journal, 2026
DOI 10.1183/13993003.congress-2026.pa630 Source: OpenAlex
-
A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma
Transfusion and Apheresis Science, 2025
DOI 10.1016/j.transci.2025.104183 PMID 40627978 Source: OpenAlex
-
The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes
Transfusion and Apheresis Science, 2025
DOI 10.1016/j.transci.2025.104186 PMID 40555163 Source: OpenAlex
-
A Case of Kappa Light-Chain Multiple Myeloma With Auer Rod-Like Inclusions and Snapper-Schneid Granules
Cureus, 2025
DOI 10.7759/cureus.83170 PMID 40303281 1 citation (Europe PMC) Open-access full textSource: OpenAlex
-
C-reactive Protein Guided Empirical Antibiotic Therapy Versus Standardized Neutropenic Fever Approach in Patients Undergoing High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation
Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2025
DOI 10.4274/bmj.galenos.2025.2024.12-1 Source: OpenAlex
-
POSTER: CT-376 Does Body Mass Index Affect Stem Cell Yield in Healthy Donors?
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/s2152-2650(25)01406-5 Source: OpenAlex
-
CT-376: Does Body Mass Index Affect Stem Cell Yield in Healthy Donors?
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/s2152-2650(25)02780-6 Source: OpenAlex